Thursday, April 2, 2020

Thursday, April 2, 2020

VETOQUINOL USA: Launches Flexprofen™


Vetoquinol USA issued the following announcement on April 23.

Vetoquinol USA, a world-class developer of veterinarian-approved formulas for animal healthcare products, announced the launch of its newest product called Flexprofen™.

Flexprofen™ is a generic, beef-flavored chewable tablet that contains carprofen, which is the most widely-used and clinically-proven non-steroidal anti-inflammatory (NSAID) used in veterinary medicine. The product is high-quality and comparable to the leading brand name carprofen chewables that address symptoms of pain and inflammation typically associated with osteoarthritis. Flexprofen™ can also be used to treat dogs with postoperative pain resulting from soft tissue and orthopedic surgeries.

"Osteoarthritis and joint care are a key strategic therapeutic target, not only for Vetoquinol USA, but for Vetoquinol globally," said Eric Alsup, Country Manager at Vetoquinol USA. "We are very pleased to have the opportunity to expand our osteoarthritis platform with the addition of Flexprofen™, a true chewable carprofen tablet that will enhance our existing offering of carprofen caplets, carprofen flavored tablets and our joint supplement line."

Flexprofen™ is scored for easy dosing and available in 25 milligrams, 75 milligrams, and 100 milligrams of carprofen per chewable in 180 count bottles. The recommended dosage for oral administration to dogs is 2 milligrams per pound of body weight daily, which may also be divided and administered as 1 milligram per pound twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. For additional prescribing information, click here.

To learn more about Vetoquinol USA and all of its oral carprofen options, visit www.vetoquinolusa.com. You can also follow on Facebook for information on animal health and care.

Original source can be found here.

Organizations in this Story

Vetoquinol USA

More News

FDA Health News